In situ liposomal preparation containing amphotericin B: Related toxicity and tissue disposition studies

Pharmaceutical Development and Technology

Volumn 5, Issue 4, 2000, Pages 543-553

  Chakraborty, K K ^a   Naik, S R ^a  

^a Hindustan Antibiotics Ltd   (India)

Author keywords

Amphotericin B; Hydroxypropyl cyclodextrin; Proliposome; Tissue distribution; Toxicity

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; AMPHOTERICIN B LIPID COMPLEX; BETA CYCLODEXTRIN; LIPOSOME; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; DILUTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG FORMULATION; IN VIVO STUDY; LD 50; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SURVIVAL; TREATMENT OUTCOME;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; DRUG CARRIERS; DRUG STABILITY; LETHAL DOSE 50; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; TISSUE DISTRIBUTION;

EID: 0033673619     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-100102037     Document Type: Article

References (28)

1. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
2. Amphotericin B lipid complex
3. Polyethylene glycol-coated (Pegylated) liposomal doxorubicin
4. Altered tissue distribution of amphotericin B by liposome encapsulation: Comparison of normal mice infected with Candida albicans
5. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice
6. Mechanism of selective toxicity of amphotericin B incorporated into liposomes
7. A simple method for the preparation of liposomes for pharmaceutical applications: Characterization of the liposomes
8. Pharmaceutical application of cyclodextrin (III) - Toxicological issues and safety evaluation
9. Interaction between lectin from ricinus communis and liposomes containing gangliosides
10. Grinding: A method for β-cyclodextrin inclusion complexation
11. Thermal analysis of drugs and drug products
12. Cyclodextrins in drug carrier systems
13. A universal reagent for phospholipid analysis
14. Simplified method of evaluating dose effects experiments
15. Quantitation of amphotericin B with use of high-pressure liquid chromatography
16. Liposomal amphotericin B in the control of experimental aspergillosis in mice: Part I - Relative therapeutic efficacy of free and liposomal amphotericin B
17. Preparation, relative toxicity and therapeutic efficacy of liposomal HA-1-92 (A new oxohexaene polyene macrolide antibiotic)
18. Invasive aspergillosis - Progress in early diagnosis and treatment
19. Pharmacokinetic analysis of in-situ liposomal preparation derived from proliposome
20. Studies of isotropic phosphotidylcholine-n-propanol-water system
21. Cryoprotection and drug leakage of in-situ liposomal preparations
22. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl β-cyclodextrin/drug complexes after intravenous injection into rats: Implications in drug delivery
23. Mins
24. Incorporation of amphotericin B (AmB) into liposomes alters AmB induced acute nephrotoxicity in rabbits